142 related articles for article (PubMed ID: 26999939)
1. [Managment of subretinal heamorrhages within the macular area using intravitreal injections of recombined tissue plasminogen activator, sulphur hexafluoride and ranihizumab--preliminary report].
Miniewicz J; Kubicka-Trząska A; Karska-Basta I; Romanowska-Dixon B
Klin Oczna; 2015; 117(3):165-8. PubMed ID: 26999939
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal Recombinant Tissue Plasminogen Activator and Sulphur Hexafluoride Gas for Submacular Haemorrhage Displacement in Age-Related Macular Degeneration: Looking behind the Blood.
Maggio E; Peroglio Deiro A; Mete M; Sartore M; Polito A; Prigione G; Guerriero M; Pertile G
Ophthalmologica; 2020; 243(3):224-235. PubMed ID: 31905361
[TBL] [Abstract][Full Text] [Related]
3. [Intravitreal injection of rt-PA and gas in the management of minor submacular haemorrhages secondary to age-related macular degeneration].
Hattenbach LO; Brieden M; Koch F; Gümbel H
Klin Monbl Augenheilkd; 2002 Jul; 219(7):512-8. PubMed ID: 12195317
[TBL] [Abstract][Full Text] [Related]
4. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.
Hassan AS; Johnson MW; Schneiderman TE; Regillo CD; Tornambe PE; Poliner LS; Blodi BA; Elner SG
Ophthalmology; 1999 Oct; 106(10):1900-6; discussion 1906-7. PubMed ID: 10519583
[TBL] [Abstract][Full Text] [Related]
5. Flattening of retinal pigment epithelial detachments after pneumatic displacement of submacular hemorrhages secondary to age-related macular degeneration.
Kimura M; Yasukawa T; Shibata Y; Kato A; Hirano Y; Uemura A; Yoshida M; Ogura Y
Graefes Arch Clin Exp Ophthalmol; 2018 Oct; 256(10):1823-1829. PubMed ID: 29961921
[TBL] [Abstract][Full Text] [Related]
6. Management of submacular hemorrhage with intravitreal sulfur hexafluoride: a pilot study.
Daneshvar H; Kertes PJ; Leonard BC; Peyman GA
Can J Ophthalmol; 1999 Dec; 34(7):385-8. PubMed ID: 10649579
[TBL] [Abstract][Full Text] [Related]
7. Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions.
Hattenbach LO; Klais C; Koch FH; Gümbel HO
Ophthalmology; 2001 Aug; 108(8):1485-92. PubMed ID: 11470706
[TBL] [Abstract][Full Text] [Related]
8. [Findings of Optical Coherence Tomography (OCT) in Submacular Haemorrhage Displacement Due to a Retinal Macroaneurysm by Intravitreal Injection of Gas and Recombinant Tissue Plasminogen Activator (rtPA)].
Stoffelns BM
Klin Monbl Augenheilkd; 2015 Apr; 232(4):566-7. PubMed ID: 25902124
[No Abstract] [Full Text] [Related]
9. Intravitreal injection of recombinant tissue plasminogen activator and pneumatic displacement of submacular haemorrhage.
Fadhilah M; Mimiwati Z; Fong KC
Med J Malaysia; 2010 Dec; 65(4):271-2. PubMed ID: 21901943
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal tissue plasminogen activator, perfluoropropane (C3F8), and ranibizumab or photodynamic therapy for submacular hemorrhage secondary to wet age-related macular degeneration.
Papavasileiou E; Steel DH; Liazos E; McHugh D; Jackson TL
Retina; 2013 Apr; 33(4):846-53. PubMed ID: 23400079
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of subretinal macular hemorrhages with intravitreous injections of tissue plasminogen activator and SF6 gas].
Oficjalska-Młyńczak J; Zajac-Pytrus H; Marek J; Nizankowska MH
Klin Oczna; 2003; 105(3-4):140-6. PubMed ID: 14552171
[TBL] [Abstract][Full Text] [Related]
12. Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator.
Hillenkamp J; Surguch V; Framme C; Gabel VP; Sachs HG
Graefes Arch Clin Exp Ophthalmol; 2010 Jan; 248(1):5-11. PubMed ID: 19669780
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study.
Meyer CH; Scholl HP; Eter N; Helb HM; Holz FG
Acta Ophthalmol; 2008 Aug; 86(5):490-4. PubMed ID: 18221499
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of acute subretinal hemorrhage in age-related macular degeneration by combined intravitreal injection of recombinant tissue plasminogen activator and gas.
Hesse L; Kroll P
Adv Ther; 1997; 14(5):275-80. PubMed ID: 10174620
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of recombinant tissue plasminogen activator and gas versus bevacizumab and gas for subretinal haemorrhage.
Mayer WJ; Hakim I; Haritoglou C; Gandorfer A; Ulbig M; Kampik A; Wolf A
Acta Ophthalmol; 2013 May; 91(3):274-8. PubMed ID: 21952010
[TBL] [Abstract][Full Text] [Related]
16. Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator.
Mizutani T; Yasukawa T; Ito Y; Takase A; Hirano Y; Yoshida M; Ogura Y
Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1153-7. PubMed ID: 21445629
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal ranibizumab injections with and without pneumatic displacement for treating submacular hemorrhage secondary to neovascular age-related macular degeneration.
Cho HJ; Koh KM; Kim JH; Kim HS; Han JI; Lew YJ; Lee TG; Kim JW
Retina; 2015 Feb; 35(2):205-12. PubMed ID: 25105310
[TBL] [Abstract][Full Text] [Related]
18. Vitrectomy with subretinal tissue plasminogen activator and ranibizumab for submacular haemorrhages secondary to age-related macular degeneration: retrospective case series of 45 consecutive cases.
González-López JJ; McGowan G; Chapman E; Yorston D
Eye (Lond); 2016 Jul; 30(7):929-35. PubMed ID: 27055681
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal injection of tissue plasminogen activator and gas bubble for treatment of subretinal hemorrhage in ARMD.
Hay SR; Madonna RJ
Optometry; 2000 Nov; 71(11):715-21. PubMed ID: 11101129
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage.
Treumer F; Roider J; Hillenkamp J
Br J Ophthalmol; 2012 May; 96(5):708-13. PubMed ID: 22174095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
